Recent insights into Immuno-Oncology

JOIN US 

COME TO MEET THE EXPERTS 
OF ANALIS & BECKMAN COULTER 

Cancer immunotherapy has revolutionized the clinical practice in multiple advanced cancers and is a fast-developing field in oncology. Over the past decade, we witnessed an extraordinary development and progress in the field of onco-immunology. The ever-expanding knowledge of the processes beyond the success of immunotherapy has leveraged novel biomarkers, next-generation cell therapies, cancer vaccines, and multi-specific antibodies, among other clinically relevant advances.

At the second edition, leading experts in cancer immunotherapy will present the latest advances in their cutting-edge research, discuss the future challenges in the field of onco-immunology, including resistance mechanisms and how to harness cellular and molecular or metabolic components of complex immune networks to optimize the combination of immunotherapy with other anticancer regimens and develop new strategies.

Compared with the first edition, the current second onco-immunology conference will focus on cellular therapies (CAR, ACT, etc.) and clinical trials, with the main aim to bring researchers closer to the most recent applications in immunotherapy.

We anticipate that the conference will provide a landmark forum to stimulate discussion and interaction among participants, researchers, healthcare professionals, and experts in this burgeoning and rapidly evolving field.

THE PROGRAM
 brings together world-recognized experts who will present their recent work in sessions focused on:

Car T Cells
Precision immuno-oncology
Immune-escape
Glycobiology in cancer
Cross-talk myeloid cells
Tumor-host interactions
Translational research
Next to an inspiring scientific program, conference participants will have ample networking opportunities during the breaks, poster sessions, and the conference dinner in a perfectly safe and stimulating environment.